OrganOx Ltd: OrganOx® Limited is a late-stage medical device development company that was founded in April 2008 as a spin-out from the University of Oxford.
The OrganOx metra™, will be commercially available in 2013 and will enable the repair, preservation and objective viability assessment of livers prior to transplantation for up to 24 hours using normothermic oxygenated blood. Through the use of the metra we aim to increase the number of livers available for transplant.
The metra utilises a patented process of “auto-regulation” allowing the liver to self-regulate pressures and flows of oxygenated blood at normothermic temperatures. The auto-regulation method and algorithms have been developed through over 15 years of research with over 200 pre-clinical perfusions reported in over 30 peer-reviewed publications and reviews.